Home/Filings/4/0001415889-23-002462
4//SEC Filing

Dekker Martin 4

Accession 0001415889-23-002462

CIK 0001600132other

Filed

Feb 13, 7:00 PM ET

Accepted

Feb 14, 4:47 PM ET

Size

5.4 KB

Accession

0001415889-23-002462

Insider Transaction Report

Form 4
Period: 2023-02-10
Dekker Martin
VP of Device Engineering
Transactions
  • Award

    Stock Options (right to buy)

    2023-02-10$1.52/sh+50,000$76,00050,000 total
    Exercise: $1.52Exp: 2033-02-10Common Stock (50,000 underlying)
Footnotes (1)
  • [F1]This option vests as to 25% of the underlying shares on February 10, 2024 and the remaining options vest quarterly over a period of 3 years thereafter.

Issuer

Bellerophon Therapeutics, Inc.

CIK 0001600132

Entity typeother

Related Parties

1
  • filerCIK 0001643049

Filing Metadata

Form type
4
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 4:47 PM ET
Size
5.4 KB